Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,828 followers.

New article: Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients https://t.co/Ci3yiMNGjR #melanoma #oncology https://t.co/YvHvUh5vnt

16 Dec 2021

Reply Repost Favourite

RT @FrontOncology: New research: Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Pa…

29 Nov 2021

Reply Repost Favourite

New research: Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients: Plasminogen activating inhibitor-1 (PAI-1) plays crucial roles in the development of various cancers, including… https://t.co/kL

29 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.